Article

Dr. Rovner on the future of midurethral slings

In this video, Eric S. Rovner, MD, discusses the importance of midurethral slings for the treatment of stress urinary incontinence.

In this video, Eric S. Rovner, MD, of the Medical University of South Carolina, Charleston, discusses the importance of midurethral slings for the treatment of stress urinary incontinence. For more on this topic, as well as the FDA ban of surgical mesh for pelvic organ prolapse, see:

‘Mesh morass’ leaves future in question

Mesh: Emotion vs. evidence

Letter: Anterior urethropexy offers excellent, low-risk option to mesh

Related Videos
Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Dr Louise Kostos answers a question during a Zoom video interview
Illustration of prostate | Image Credit: © Judith - stock.adobe.com
Medcast series
Related Content
Data refute concerns about telehealth as Congress weighs legislation
March 7th 2025

Data refute concerns about telehealth as Congress weighs legislation

Hannah Clarke
“Five years after telehealth suddenly became a routine part of care for most Americans, we show that it has not led to runaway utilization or spending. This kind of in-depth analysis can inform its future," says Chad Ellimoottil, MD, MS.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Identifying unique therapeutic targets for chromophobe kidney cancer
March 6th 2025

Identifying unique therapeutic targets for chromophobe kidney cancer

David A. Braun, MD, PhD Hannah Clarke
“What we hope overall is that this is a biological study that might inform therapeutic development for this disease,” says David A. Braun, MD, PhD.
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Study links poor semen quality with shorter life span
March 5th 2025

Study links poor semen quality with shorter life span

Hannah Clarke
The average life expectancy was 80.3 years among men with a total motile sperm count over 120 million, compared with 77.6 years among men with a total motile sperm count ranging from >0 to 5 million.
FDA greenlights pivotal trial of Voro Urologic Scaffold for postprostatectomy SUI
March 4th 2025

FDA greenlights pivotal trial of Voro Urologic Scaffold for postprostatectomy SUI

Hannah Clarke
The ARID II trial is assessing the safety and effectiveness of the device in men who are scheduled to undergo robotic-assisted radical prostatectomy.
© 2025 MJH Life Sciences

All rights reserved.